Today's announcement ""BRN receives US export approval" made me wonder...
Given that:
"The Export Administration Regulations (EAR) classification of EAR99, which BrainChip has formally received, is a classification under the EAR which
removes barriers for exporting Akida™ to non-U.S. countries, and to non-restricted customers and use cases. The EAR99 designation (CCATS G818400), received on February 14, 2020 for the Akida Neuromorphic System-on-Chip (NSoC), the BrainChip
Akida Development Environment (ADE), and related Akida technologies means that the company does not require a pre-approval, or a license from the U.S. Department of Commerce, before delivering its solutions globally as part of sales and market expansion activities.
And that:
BrainChip Unveils the Akida™ Development Environment (24 July 2018)
https://www.asx.com.au/asxpdf/20180725/pdf/43wrd193pvlmhs.pdf
"The
Akida Development Environment is currently available on an early-access program to approved customers."
BrainChip Unveils the Akida™ Development Environment (24 July 2018)
https://www.brainchipinc.com/news-m...hip-unveils-the-akida-development-environment
"The
Akida Development Environment is currently available on an early-access program to approved customers."
Additionally that:
BrainChip December 2018 Quarter Update Presentation (February 01, 2019)
https://www.finnewsnetwork.com.au/archives/finance_news_network221917.html
"
The Akida development environment is, as we've talked about before, it's a fully simulated Akida device that runs in software. It has all the learning rules, it has all the neuro fabric, but running software."
"But that
intellectual property sale would carry an immediate licence and an ongoing royalty. This again is one of those areas where
long before we get the chip out, we could be generating revenue on the Akida intellectual property. With the
Akida development environment, we may have an opportunity to take the development environment, put a wrapper around it for specific use cases, whether it's cybersecurity or whether it's, you know, something in the IOT space, but be
able to generate revenue off of the development environment as a custom solution for a very specific use case, or intellectual property for integration into a larger SOC.
These are important transactions, again, because they could generate revenue from Akida in advance of actually releasing the neuromorphic system on a chip."
Please correct me if I'm wrong, but by their own account, BrainChip may have had the ability to generate revenue from the Akida Development Environment, since as early as the 24th of July 2018. I assume that BrainChip have had no restrictions delivering their solutions to US-based target customers and that those US-based target customers have been able to access the Akida Development Environment since the 24th of July 2018? Can we infer that US-based target customers have not been
significantly interested in the Akida IP (at least not that the market is aware of), as no revenue has been generated from the Akida IP since the 24th of July 2018? Or perhaps no opportunities in the US have presented themselves to date in relation to the Akida IP?
(20min delay)